LIQUID PHARMACEUTICAL COMPOSITIONS

A liquid pharmaceutical composition for use in a pressurized metered dose inhaler (pMDI), which composition comprises a pharmaceutically acceptable addition salt of (i) carcainium, and (ii) sulfuric acid, hydrochloric acid, hydrobromic acid, maleic acid or 1-hydroxy-2-naphthoic acid(xinafoic acid)....

Full description

Saved in:
Bibliographic Details
Main Authors CHOI, LEWIS SIU LEUNG, PLOUVIER, BERTRAND MICHEL CLAUDE, NORTHEN, JULIAN SCOTT, SPARGO, PETER LIONEL, FRENCH, EDWARD JAMES
Format Patent
LanguageEnglish
French
Published 13.03.2014
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A liquid pharmaceutical composition for use in a pressurized metered dose inhaler (pMDI), which composition comprises a pharmaceutically acceptable addition salt of (i) carcainium, and (ii) sulfuric acid, hydrochloric acid, hydrobromic acid, maleic acid or 1-hydroxy-2-naphthoic acid(xinafoic acid). L'invention concerne une composition pharmaceutique liquide destinée à être utilisée dans un inhalateur doseur pressurisé (IDP), la composition comprenant un sel d'addition pharmaceutiquement acceptable de (i) carcaïnium et de (ii) acide sulfurique, acide chlorhydrique, acide bromhydrique, acide maléique ou acide 1-hydroxy-2-naphtoïque (acide xinafoïque).
Bibliography:Application Number: WO2013GB52325